The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
Abstract
Purpose: Risk stratification in acute myeloid leukemia (AML) is currently based on pretreatment characteristics. It remains to be established whether relapse risk can be better predicted through assessment of minimal residual disease (MRD). One proposed marker is the Wilms tumor gene WT1, which is overexpressed in most patients with AML, thus providing a putative target for immunotherapy, although in the absence of a standardized assay, its utility for MRD monitoring remains controversial. Patients and Methods: Nine published and in-house real-time quantitative polymerase chain reaction WT1 assays were systematically evaluated within the European LeukemiaNet; the best-performing assay was applied to diagnostic AML samples (n = 620), follow-up samples from 129 patients treated with intensive combination chemotherapy, and 204 normal peripheral blood (PB) and bone marrow (BM) controls. Results: Considering relative levels of expression detected in normal PB and BM, WT1 was sufficiently overexpressed to discriminate ≥ 2-log reduction in transcripts in 46% and 13% of AML patients, according to the respective follow-up sample source. In this informative group, greater WT1 transcript reduction after induction predicted reduced relapse risk (hazard ratio, 0.54 per log reduction; 95% CI, 0.36 to 0.83; P = .004) that remained significant when adjusted for age, WBC count, and cytogenetics. Failure to reduce WT1 transcripts below the threshold limits defined in normal controls by the end of consolidation also predicted increased relapse risk (P = .004). Conclusion: Application of a standardized WT1 assay provides independent prognostic information in AML, lending support to incorporation of early assessment of MRD to develop more robust risk scores, to enhance risk stratification, and to identify patients who may benefit from allogeneic transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,655
Self-citationCheson, B. D., Bennett, J. M., Kopecky, K. J., Büchner, T., Willman, C. L., Estey, E. H., Schiffer, C. A., Doehner, H., Tallman, M. S., Lister, T. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.036 · Cited by 2,654
Creutzig, U., & Kaspers, G. J. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.99.116 · Cited by 2,137
Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype
Falini, B., Mecucci, C., Tiacci, E., Alcalay, M., Rosati, R., Pasqualucci, L., La Starza, R., Diverio, D., Colombo, E., Santucci, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041974 · Cited by 1,892
Self-citationMutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
Schlenk, R. F., Döhner, K., Krauter, J., Fröhling, S., Corbacioglu, A., Bullinger, L., Habdank, M., Späth, D., Morgan, M., Benner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074306 · Cited by 1,628
Estey, E., & Döhner, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69780-8 · Cited by 1,296
Gabert, J., Beillard, E., van der Velden, V. H. J., Bi, W., Grimwade, D., Pallisgaard, N., Barbany, G., Cazzaniga, G., Cayuela, J. M., Cavé, H., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403135 · Cited by 1,284
Self-citationBeillard, E., Pallisgaard, N., van der Velden, V. H. J., Bi, W., Dee, R., van der Schoot, E., Delabesse, E., Macintyre, E., Gottardi, E., Saglio, G., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403136 · Cited by 881
Self-citationCytogenetics in acute leukemia
Mrózek, K., Heerema, N. A., & Bloomfield, C. D. (2004) · Blood Reviews · doi:10.1016/s0268-960x(03)00040-7 · Cited by 659
Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., Kita, K., Hiraoka, A., Masaoka, T., & Nasu, K. (1994) · Blood · doi:10.1182/blood.v84.9.3071.3071 · Cited by 575
Wheatley, K., Burnett, A. K., Goldstone, A. H., Gray, R. G., Hann, I. M., Harrison, C. J., Rees, J. K. H., Stevens, R. F., & Walker, H. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01684.x · Cited by 434
Aberrant Overexpression of the Wilms Tumor Gene (WT1) in Human Leukemia
Inoue, K., Ogawa, H., Sonoda, Y., Kimura, T., Sakabe, H., Oka, Y., Miyake, S., Tamaki, H., Oji, Y., Yamagami, T., et al. (1997) · Blood · doi:10.1182/blood.v89.4.1405 · Cited by 371
Grimwade, D., Jovanovic, J. V., Hills, R. K., Nugent, E. A., Patel, Y., Flora, R., Diverio, D., Jones, K., Aslett, H., Batson, E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1533 · Cited by 356
Self-citationLugthart, S., van Drunen, E., van Norden, Y., van Hoven, A., Erpelinck, C. A. J., Valk, P. J. M., Beverloo, H. B., Löwenberg, B., & Delwel, R. (2008) · Blood · doi:10.1182/blood-2007-10-119230 · Cited by 280
Paschka, P., Marcucci, G., Ruppert, A. S., Whitman, S. P., Mrózek, K., Maharry, K., Langer, C., Baldus, C. D., Zhao, W., Powell, B. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2058 · Cited by 258
Cilloni, D., Gottardi, E., De Micheli, D., Serra, A., Volpe, G., Messa, F., Rege-Cambrin, G., Guerrasio, A., Divona, M., Lo Coco, F., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402675 · Cited by 245
Self-citationOgawa, H., Tamaki, H., Ikegame, K., Soma, T., Kawakami, M., Tsuboi, A., Kim, E. H., Hosen, N., Murakami, M., Fujioka, T., et al. (2003) · Blood · doi:10.1182/blood-2002-06-1831 · Cited by 228
Virappane, P., Gale, R., Hills, R., Kakkas, I., Summers, K., Stevens, J., Allen, C., Green, C., Quentmeier, H., Drexler, H., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.0333 · Cited by 218
Self-citationØstergaard, M., Olesen, L. H., Hasle, H., Kjeldsen, E., & Hokland, P. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04952.x · Cited by 200
Gaidzik, V. I., Schlenk, R. F., Moschny, S., Becker, A., Bullinger, L., Corbacioglu, A., Krauter, J., Schlegelberger, B., Ganser, A., Döhner, H., et al. (2009) · Blood · doi:10.1182/blood-2008-10-183392 · Cited by 190
Inoue, K., Ogawa, H., Yamagami, T., Soma, T., Tani, Y., Tatekawa, T., Oji, Y., Tamaki, H., Kyo, T., Dohy, H., et al. (1996) · Blood · doi:10.1182/blood.v88.6.2267.bloodjournal8862267 · Cited by 183
Büchner, T., Berdel, W. E., Schoch, C., Haferlach, T., Serve, H. L., Kienast, J., Schnittger, S., Kern, W., Tchinda, J., Reichle, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5013 · Cited by 179
Self-citationLapillonne, H., Renneville, A., Auvrignon, A., Flamant, C., Blaise, A., Perot, C., Lai, J.-L., Ballerini, P., Mazingue, F., Fasola, S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.5303 · Cited by 164
Self-citationD. Kottaridis, P., Gale, R. E., & Linch, D. C. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04500.x · Cited by 158
Mrózek, K., & Bloomfield, C. D. (2006) · Hematology · doi:10.1182/asheducation-2006.1.169 · Cited by 141
Trka, J., Kalinová, M., Hrušák, O., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402512 · Cited by 118
Development of Minimal Residual Disease–Directed Therapy in Acute Myeloid Leukemia
Freeman, S. D., Jovanovic, J. V., & Grimwade, D. J. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.04.009 · Cited by 99
Self-citationCilloni, D., Messa, F., Arruga, F., et al. (2008) · Haematologica · doi:10.3324/haematol.12165 · Cited by 94
Self-citationGarg, M. K., Moore, H. A., Tobal, K., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04552.x · Cited by 92
Greiner, J., Döhner, H., & Schmitt, M. W. (2006) · PubMed · Cited by 90
WT1-specific T cell receptor gene therapy: Improving TCR function in transduced T cells
Stauss, H. J., Thomas, S., Cesco-Gaspere, M., Hart, D. P., Xue, S., Holler, A., King, J. P., Wright, G. P., Perro, M., Pospori, C., et al. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.06.018 · Cited by 51
Lo‐Coco, F., Cuneo, A., Pane, F., Cilloni, D., Diverio, D., Mancini, M., Testoni, N., Bardi, A., Izzo, B., Bolli, N., et al. (2008) · Haematologica · doi:10.3324/haematol.12004 · Cited by 21
Self-citationZhao, B., Chauhan, A. K., Patten, I. S., Dockal, M., Scheiflinger, F., & Wagner, D. D. (2008) · Blood · doi:10.1182/blood.v112.11.259.259 · Cited by 2
Cited by
Schuurhuis, G. J., Heuser, M., Freeman, S., Béné, M.-C., Buccisano, F., Cloos, J., Grimwade, D., Haferlach, T., Hills, R. K., Hourigan, C. S., et al. (2018) · Blood · doi:10.1182/blood-2017-09-801498 · Cited by 1,041
Self-citationHeuser, M., Freeman, S. D., Ossenkoppele, G. J., Buccisano, F., Hourigan, C. S., Ngai, L. L., Tettero, J. M., Bachas, C., Baer, C., Béné, M.-C., et al. (2021) · Blood · doi:10.1182/blood.2021013626 · Cited by 763
Self-citationKrönke, J., Schlenk, R. F., Jensen, K.-O., Tschürtz, F., Corbacioglu, A., Gaidzik, V. I., Paschka, P., Onken, S., Eiwen, K., Habdank, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.0371 · Cited by 399
Short, N. J., Zhou, S., Fu, C., Berry, D. A., Walter, R. B., Freeman, S. D., Hourigan, C. S., Huang, X., Nogueras Gonzalez, G., Hwang, H., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.4600 · Cited by 390
Van Tendeloo, V. F., Van de Velde, A., Van Driessche, A., Cools, N., Anguille, S., Ladell, K., Gostick, E., Vermeulen, K., Pieters, K., Nijs, G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008051107 · Cited by 377
Metadata
- Authors
- Cilloni, D., Renneville, A., Hermitte, F., Hills, R. K., Daly, S., Jovanovic, J. V., Gottardi, E., Fava, M., Schnittger, S., Weiss, T., Izzo, B., Nomdedeu, J., van der Heijden, A., van der Reijden, B. A., Jansen, J. H., van der Velden, V. H. J., Ommen, H., Preudhomme, C., Saglio, G., & Grimwade, D.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-11-01
- Volume
- 27
- Issue
- 31
- Pages
- 5195-5201
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2104127840
- Cited by
- 445
- References
- 33
- FWCI
- 18.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.